BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,410
-680 (-4.23%)
Mar 28, 2025, 3:30 PM KST
7.24%
Market Cap 490.77B
Revenue (ttm) 130.05B
Net Income (ttm) -35.07B
Shares Out 31.85M
EPS (ttm) -1,126.00
PE Ratio n/a
Forward PE 34.59
Dividend n/a
Ex-Dividend Date n/a
Volume 202,851
Average Volume 534,068
Open 16,100
Previous Close 16,090
Day's Range 15,410 - 16,220
52-Week Range 12,100 - 27,300
Beta 0.53
RSI 40.31
Earnings Date Feb 28, 2025

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 582
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.